Medpace (MEDP) Proxy Filing summary

Executive summary

• Annual meeting scheduled for May 16, 2025, with virtual participation available for shareholders.

• Shareholders are encouraged to review proxy materials and vote by May 15, 2025.

Voting matters and shareholder proposals

• Election of two directors: August J. Troendle and Dani S. Zander, with board recommendation to vote for both.

• Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2025.

• Advisory vote on executive compensation for named executive officers.

• Approval sought for the 2016 Amended and Restated Incentive Award Plan.

• Stockholder proposal on implementing simple majority voting, with board recommending against.

Board of directors and corporate governance

• Board of Directors will oversee the meeting and any business that may arise, including adjournments or continuations.